{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Sriudomporn S"],"funding":["World Health Organization"],"pagination":["100256"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9850055"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["13"],"pubmed_abstract":["Understanding the level of investment needed for the next decade is vital to achieve the goal of Immunization Agenda 2030 (IA2030). Through the immunization funder perspective, this study estimates both global and regional economic resources required to achieve IA2030 coverage among 194 WHO member countries from 2021 to 2030, against 14 pathogens: Hepatitis B (Hep B), <i>Haemophilus influenzae</i> type b (Hib), Human papillomavirus (HPV), Japanese encephalitis (JE), Measles, Meningitis A (Men A), Streptococcus pneumoniae, Rotavirus, Rubella, Yellow Fever (YF), Diphtheria, Tetanus, Pertussis, and Tuberculosis. The total cost of immunization program, routine vaccine, routine delivery, and non-routine costs (SIA and stockpile) were estimated using WHO coverage forecast for IA2030. Incremental"],"journal":["Vaccine: X"],"pubmed_title":["Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021-2030."],"pmcid":["PMC9850055"],"funding_grant_id":["001"],"pubmed_authors":["Watts E","Patenaude B","Yoon Sim S","Sriudomporn S","Hutubessy R"],"additional_accession":[]},"is_claimable":false,"name":"Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021-2030.","description":"Understanding the level of investment needed for the next decade is vital to achieve the goal of Immunization Agenda 2030 (IA2030). Through the immunization funder perspective, this study estimates both global and regional economic resources required to achieve IA2030 coverage among 194 WHO member countries from 2021 to 2030, against 14 pathogens: Hepatitis B (Hep B), <i>Haemophilus influenzae</i> type b (Hib), Human papillomavirus (HPV), Japanese encephalitis (JE), Measles, Meningitis A (Men A), Streptococcus pneumoniae, Rotavirus, Rubella, Yellow Fever (YF), Diphtheria, Tetanus, Pertussis, and Tuberculosis. The total cost of immunization program, routine vaccine, routine delivery, and non-routine costs (SIA and stockpile) were estimated using WHO coverage forecast for IA2030. Incremental","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2026-03-31T10:39:55.907Z","creation":"2025-04-19T06:48:48.314Z"},"accession":"S-EPMC9850055","cross_references":{"pubmed":["36686400"],"doi":["10.1016/j.jvacx.2022.100256"]}}